BeStock  

Xeris Pharmaceuticals XERS

US equityMarket cap rank #2842Drug Manufacturers - Specialty & Generic
$10.13 +$1.05 (+11.56%)
Pre-market · Oct 6, 5:10 am ET · After hours $10.11 -0.20%
Open$9.15
Prev close$9.08
Day range$9.12 – $10.24
Volume4.66M
Market cap$1.85B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$11.60+14.5% vs. price
  • Buy 80%
  • Hold 20%
Low $8.00Now $10.13Avg $11.60High $16.00

Recent rating changes

The last 20 actions on file set price targets from $8.00 to $16.00, averaging $10.75.

DateFirmRatingTarget
29 Sep 2026 Craig-Hallum BUY $12.00
21 Sep 2026 H.C. Wainwright BUY $10.00
10 Sep 2026 Craig-Hallum BUY $12.00
10 Sep 2026 Piper Sandler HOLD $8.00
10 Sep 2026 Leerink Partners BUY $16.00
10 Sep 2026 H.C. Wainwright BUY $10.00
20 Aug 2026 Barclays BUY $12.00
7 Aug 2026 Piper Sandler HOLD $8.00
7 Aug 2026 H.C. Wainwright BUY $10.00
8 Jul 2026 Craig-Hallum BUY $12.00
30 Jun 2026 Craig-Hallum BUY –
11 Jun 2026 Craig-Hallum BUY –
13 May 2026 Barclays BUY $9.00
8 May 2026 Craig-Hallum BUY $12.00
8 May 2026 H.C. Wainwright BUY $10.00
6 May 2026 Craig-Hallum BUY –
28 Apr 2026 Craig-Hallum BUY $12.00
19 Mar 2026 Barclays BUY $9.00
3 Mar 2026 Craig-Hallum BUY –
2 Mar 2026 H.C. Wainwright BUY $10.00

Discussion

No comments yet — be the first to weigh in on XERS.

Leave a comment

Scroll to Top